Search

everythinglearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

JAK inhibitors are effective treatments for alopecia areata.

Lokivetmab reduced itching in a dog with skin lymphoma.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Switching from escitalopram to duloxetine improved hair loss.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.